466 related articles for article (PubMed ID: 23287468)
1. The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells.
Vazquez-Martin A; Corominas-Faja B; Cufi S; Vellon L; Oliveras-Ferraros C; Menendez OJ; Joven J; Lupu R; Menendez JA
Cell Cycle; 2013 Jan; 12(2):207-18. PubMed ID: 23287468
[TBL] [Abstract][Full Text] [Related]
2. Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.
Vazquez-Martin A; Vellon L; Quirós PM; Cufí S; Ruiz de Galarreta E; Oliveras-Ferraros C; Martin AG; Martin-Castillo B; López-Otín C; Menendez JA
Cell Cycle; 2012 Mar; 11(5):974-89. PubMed ID: 22333578
[TBL] [Abstract][Full Text] [Related]
3. Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives.
Menendez JA
Biochim Biophys Acta; 2010 Mar; 1801(3):381-91. PubMed ID: 19782152
[TBL] [Abstract][Full Text] [Related]
4. The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival.
García-Bermúdez J; Cuezva JM
Biochim Biophys Acta; 2016 Aug; 1857(8):1167-1182. PubMed ID: 26876430
[TBL] [Abstract][Full Text] [Related]
5. Increased lipogenesis in cancer cells: new players, novel targets.
Swinnen JV; Brusselmans K; Verhoeven G
Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):358-65. PubMed ID: 16778563
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated lipid metabolism in hepatocellular carcinoma cancer stem cells.
Bort A; Sánchez BG; de Miguel I; Mateos-Gómez PA; Diaz-Laviada I
Mol Biol Rep; 2020 Apr; 47(4):2635-2647. PubMed ID: 32125560
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype.
Sánchez-Cenizo L; Formentini L; Aldea M; Ortega AD; García-Huerta P; Sánchez-Aragó M; Cuezva JM
J Biol Chem; 2010 Aug; 285(33):25308-13. PubMed ID: 20538613
[TBL] [Abstract][Full Text] [Related]
8. Post-transcriptional regulation of the mitochondrial H(+)-ATP synthase: a key regulator of the metabolic phenotype in cancer.
Willers IM; Cuezva JM
Biochim Biophys Acta; 2011 Jun; 1807(6):543-51. PubMed ID: 21035425
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and B-Cell Growth Transformation Induce Lipogenesis through Fatty Acid Synthase.
Hulse M; Johnson SM; Boyle S; Caruso LB; Tempera I
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208446
[TBL] [Abstract][Full Text] [Related]
10. Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells.
Prigione A; Adjaye J
Int J Dev Biol; 2010; 54(11-12):1729-41. PubMed ID: 21305470
[TBL] [Abstract][Full Text] [Related]
11. Effects of short- and long-chain fatty acids on the expression of stearoyl-CoA desaturase and other lipogenic genes in bovine mammary epithelial cells.
Jacobs AA; Dijkstra J; Liesman JS; Vandehaar MJ; Lock AL; van Vuuren AM; Hendriks WH; van Baal J
Animal; 2013 Sep; 7(9):1508-16. PubMed ID: 23597233
[TBL] [Abstract][Full Text] [Related]
12. Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.
Folmes CD; Martinez-Fernandez A; Faustino RS; Yamada S; Perez-Terzic C; Nelson TJ; Terzic A
J Cardiovasc Transl Res; 2013 Feb; 6(1):10-21. PubMed ID: 23247633
[TBL] [Abstract][Full Text] [Related]
13. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging.
Menendez JA; Vellon L; Oliveras-Ferraros C; Cufí S; Vazquez-Martin A
Cell Cycle; 2011 Nov; 10(21):3658-77. PubMed ID: 22052357
[TBL] [Abstract][Full Text] [Related]
14. mTORC2 Regulates Lipogenic Gene Expression through PPAR
Guo Z; Zhao K; Feng X; Yan D; Yao R; Chen Y; Bao L; Wang Z
Biomed Res Int; 2019; 2019():5196028. PubMed ID: 31223619
[TBL] [Abstract][Full Text] [Related]
15. Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells.
Loubière C; Goiran T; Laurent K; Djabari Z; Tanti JF; Bost F
Oncotarget; 2015 Jun; 6(17):15652-61. PubMed ID: 26002551
[TBL] [Abstract][Full Text] [Related]
16. PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis.
Bhalla K; Hwang BJ; Dewi RE; Ou L; Twaddel W; Fang HB; Vafai SB; Vazquez F; Puigserver P; Boros L; Girnun GD
Cancer Res; 2011 Nov; 71(21):6888-98. PubMed ID: 21914785
[TBL] [Abstract][Full Text] [Related]
17. HIF1α modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2.
Prigione A; Rohwer N; Hoffmann S; Mlody B; Drews K; Bukowiecki R; Blümlein K; Wanker EE; Ralser M; Cramer T; Adjaye J
Stem Cells; 2014 Feb; 32(2):364-76. PubMed ID: 24123565
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-CoA carboxylase 2-/- mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions.
Abu-Elheiga L; Wu H; Gu Z; Bressler R; Wakil SJ
J Biol Chem; 2012 Apr; 287(15):12578-88. PubMed ID: 22362781
[TBL] [Abstract][Full Text] [Related]
19. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming.
Folmes CD; Nelson TJ; Martinez-Fernandez A; Arrell DK; Lindor JZ; Dzeja PP; Ikeda Y; Perez-Terzic C; Terzic A
Cell Metab; 2011 Aug; 14(2):264-71. PubMed ID: 21803296
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
